Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
7.00    -0.66 (-8.62%)
Bid:
6.90
Ask:
7.10
Spread: 0.20 (2.899%)
Market Cap: £34.47m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Exercise of Warrants

16 Dec 2025 11:47

RNS Number : 7909L
Blencowe Resources PLC
16 December 2025
 

16 December 2025

Blencowe Resources Plc (the "Company")

Exercise of Warrants

 

The Company has received notices for an aggregate of 9,066,667 warrants resulting from the exercise of 5,750,000 warrants at the issue prices of 6p and 3,316,667 warrants at the issue price of 4.5p resulting in the receipt of approximately £494,000. The Company will issue a total of 9,066,667 New Ordinary Shares.

The Company has raised approximately £1,254,000 from the exercise of warrants since 1 October 2025.

Admission

The Company will make an application for 9,066,667 New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 22 December 2025.

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 463,670,645 Ordinary Shares, each with one vote. The Company does not hold any Ordinary Shares in Treasury. On Admission, the total number of voting rights in the Company is expected to be 463,670,645 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 Blencowe Resources Plc

 Sam Quinn

 

www.blencoweresourcesplc.com

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

Investor Relations

Sasha Sethi

Tel: +44 (0) 7891 677 441

sasha@flowcomms.com

Tavira Financial

Jonathan Evans

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

OAK Securities (a trading name of Merlin Partners LLP)

 

Calvin Man /Mungo Sheehan / Jerry Keen

 

 

 

Tel: +44 (0)20 3973 3678

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOETFBBTMTIBBAA
Date   Source Headline
22nd Jun 20267:51 amRNS-RCavendish Publishes Initiation Research
12th Jun 20264:35 pmRNSBlock Admission Six Monthly Return
4th Jun 20267:01 amRNS-ROak Securities Research Note Following DFS Update
2nd Jun 202610:45 amRNSExercise of Share Options
29th May 20267:00 amRNSOrom Cross Graphite DFS NPV10 up 15% to US$1.254bn
28th May 20267:04 amRNS-RAppointment of Joint Broker
26th May 202612:46 pmRNSHalf-year Financial Report
18th May 20267:00 amRNSBeehive Deposit Maiden JORC Resource
7th May 20267:36 amRNSRocket Component Testing Programme
30th Apr 20267:00 amRNSBeehive Final Assay Results
16th Apr 20267:00 amRNSBeehive Drilling Results
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
17th Mar 20267:00 amRNSBeehive Drilling Returns Multiple 30m Intercepts
13th Mar 202612:57 pmRNSEXERCISE OF SHARE OPTIONS
6th Mar 20267:00 amRNSMaiden 16.9 Mt JORC Resource for Iyan Deposit
26th Feb 20262:57 pmRNSResult of AGM
24th Feb 20267:00 amRNSFinal Ilyan Drilling Results
20th Feb 202611:03 amRNSLong Term Incentive Programme
16th Feb 20267:00 amRNSUS AD/CVD Ruling Supports Non-China Supply
10th Feb 20267:00 amRNSHigh Value Synthetic Diamond Manufacture
6th Feb 20267:00 amRNSIyan - Further Significant Graphite Intercepts
2nd Feb 20267:00 amRNSIyan Deposit Delivers Multiple Intercepts over 30M
30th Jan 202611:29 amRNSAnnual Financial Report
23rd Jan 20267:57 amRNSEuropean Processing & Offtake with Alkeemia
15th Jan 20267:14 amRNSTestwork Confirms Highest Purity
13th Jan 202610:50 amRNSBlock Listing Application
13th Jan 20267:00 amRNS-RBroker Research Initiation
9th Jan 20267:00 amRNSBeehive Delivers 2 Standout +90 metre Intercepts
7th Jan 20269:17 amRNSDFS Performance Shares - Replacement
7th Jan 20268:25 amRNSExercise of Warrants
5th Jan 20264:14 pmRNSExercise of Warrants
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
30th Dec 202510:54 amRNSIssue of DFS Performance Shares
23rd Dec 20257:00 amRNSBeehive Returns 92.55m @ 6.83% TGC from Surface
18th Dec 20257:00 amRNSFurther Strong Deep-Hole Results at Iyan
16th Dec 202511:47 amRNSExercise of Warrants
12th Dec 20257:00 amRNSExceptional Iyan Deep Hole Highlights Scale
11th Dec 20257:00 amRNSFundraise of £3m
9th Dec 20257:01 amRNSOfftake MOU with Yunasko Ltd.
9th Dec 20257:00 amRNSExercise of Warrants
8th Dec 20253:46 pmRNSExercise of Warrants
2nd Dec 20257:00 amRNSExercise of Share Options
1st Dec 20258:58 amRNS-RPresentation & Interview
1st Dec 20257:00 amRNSDFS Results Confirms Outstanding Economics
27th Nov 20257:00 amRNSJORC Resource Upgrade
25th Nov 202510:30 amRNSPublication of a Prospectus
17th Nov 20257:00 amRNSExercise of Warrants
13th Nov 202512:08 pmRNSExercise of Warrants
13th Nov 20258:30 amRNS-RResourcing Tomorrow Conference
12th Nov 202510:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.